ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021

Duke University Settles 11 Medical Malpractice Cases Related to Potti’s trials

December 9, 2011

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

Adriamycin Update Discussed At Seminar

January 10, 1975

Gallo’s Deputy Removed Pending Investigation

January 11, 1991